An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer
- 4 November 2016
- journal article
- editorial
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 25 (2) , 341-343
Abstract
The purpose of this study is to assess the efficacy of oral Vitamin C as an opioid-sparing agent when used in conjunction with opioids and standard adjuvant therapy in the management of chronic cancer pain. An open-label pilot study of patients ≥18 years of age with chronic pain secondary to cancer and/or its treatment and a Brief Pain Inventory average pain score of ≥3/10. In addition to opioid analgesia, patients received 1 g of vitamin C twice daily over 3 days (total daily dose of 2 g). Patients’ usual medications, including breakthrough medications, were continued throughout the study period. The primary endpoint was total daily opioid use during vitamin C administration compared with that immediately prior to study. Thirty-four patients were enrolled in the study. Seven failed to complete the trial. Across the 17 evaluable patients, the median daily opioid consumption was 360 mg oral morphine equivalents (OME) on the days prior to vitamin C and 390 mg when administered with vitamin C. This study failed to demonstrate any clinically significant benefit from vitamin C in conjunction with opioids in cancer-related pain and does not provide support for embarking on a larger randomised trial to determine efficacy.Keywords
Funding Information
- Mater Palliative and Supportive Care Research Fund
- Mater Research seeding grant (none)
This publication has 12 references indexed in Scilit:
- Effect of Perioperative Vitamin C Supplementation on Postoperative Pain and the Incidence of Chronic Regional Pain SyndromeThe Clinical Journal of Pain, 2016
- The Edmonton Classification System for Cancer Pain: Comparison of Pain Classification Features and Pain Intensity Across Diverse Palliative Care Settings in Eight CountriesJournal of Palliative Medicine, 2013
- Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Toxicity of Subcutaneous Ketamine in the Management of Cancer PainJournal of Clinical Oncology, 2012
- Effect of vitamin C on morphine use after laparoscopic cholecystectomy: a randomized controlled trialCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2012
- Effect of High Dose Vitamin C Supplementation on Muscle Soreness, Damage, Function, and Oxidative Stress to Eccentric ExerciseInternational Journal of Sport Nutrition and Exercise Metabolism, 2006
- Combined Antioxidant Therapy Reduces Pain and Improves Quality of Life in Chronic PancreatitisJournal of Gastrointestinal Surgery, 2006
- Ascorbic acid decreases morphine self-administration and withdrawal symptoms in ratsPathophysiology, 2005
- Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years LaterIntegrative Cancer Therapies, 2005
- A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002Journal of Pain and Symptom Management, 2004
- [Reduced pain from osteoarthritis in hip joint or knee joint during treatment with calcium ascorbate. A randomized, placebo-controlled cross-over trial in general practice].2003